Mainz, Germany

Tim Bleith

This inventor holds 2 USPTO granted patents and 3 published patent applications and 4 EPO patents. Top assignee: Evonik Operations Gmbh. Active years: 2022-2026.

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Tim Bleith - Innovator in Keto-Functionalized Aromatic (Meth)Acrylates

Introduction

Tim Bleith is a notable inventor based in Mainz, Germany. He has made significant contributions to the field of chemistry, particularly in the preparation of keto-functionalized aromatic (meth)acrylates. His innovative approach has led to the development of a unique method that enhances the efficiency and effectiveness of these compounds.

Latest Patents

Tim Bleith holds 1 patent for his invention titled "Method for preparing keto-functionalized aromatic (meth)acrylates." This patent outlines a novel method that streamlines the synthesis of these important chemical compounds, which have various applications in the industry.

Career Highlights

Tim is currently employed at Evonik Operations GmbH, a leading global company specializing in specialty chemicals. His work at Evonik has allowed him to apply his expertise in a practical setting, contributing to the company's innovative projects and research initiatives.

Collaborations

Throughout his career, Tim has collaborated with talented colleagues, including Steffen Krill and Thorben Schütz. These partnerships have fostered a creative environment that encourages the exchange of ideas and the advancement of innovative solutions.

Conclusion

Tim Bleith is a distinguished inventor whose work in keto-functionalized aromatic (meth)acrylates has made a significant impact in the field of chemistry. His contributions continue to influence the industry and inspire future innovations.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…